ASX:BIT

Biotron (BIT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.03 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.08%
Price Target
N/A
BIT stock logo

About Biotron Stock (ASX:BIT)

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

BIT Stock News Headlines

BBC micro:bit playground survey
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
The Best Multi-Bit Screwdriver
BBC micro:bit - the next gen
Biotron Limited (BIT.AX)
Biotron Drug Effective Against COVID-19 In Animals
See More Headlines
Receive BIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-4,020,000.00
Net Margins
-244.54%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.65 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.59
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Dr. Michelle Miller BSc.
    GCertAppFin, MSc., Ph.D., MD & Executive Director
  • Mr. Peter James Nightingale B.Econ (Age 67)
    CA, Company Secretary
    Comp: $120k
  • Dr. Stephen L. Becker M.D.
    Chief Medical Officer

BIT Stock Analysis - Frequently Asked Questions

This page (ASX:BIT) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners